Glassman Wealth Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-43
| Closed | -$4.15K | – | 425 |
|
|
2023
Q4 | $4.15K | Sell |
43
-160
| -79% | -$15.4K | ﹤0.01% | 1131 |
|
|
2023
Q3 | $18K | Sell |
203
-62
| -23% | -$5.49K | ﹤0.01% | 679 |
|
|
2023
Q2 | $23K | Buy |
265
+1
| +0.4% | +$87 | ﹤0.01% | 589 |
|
|
2023
Q1 | $25.7K | Buy |
264
+8
| +3% | +$778 | ﹤0.01% | 576 |
|
|
2022
Q4 | $26.5K | Buy |
256
+9
| +4% | +$931 | ﹤0.01% | 590 |
|
|
2022
Q3 | $21K | Hold |
247
| – | – | ﹤0.01% | 598 |
|
|
2022
Q2 | $20K | Sell |
247
-87
| -26% | -$7.05K | ﹤0.01% | 616 |
|
|
2022
Q1 | $26K | Buy |
334
+58
| +21% | +$4.52K | ﹤0.01% | 564 |
|
|
2021
Q4 | $24K | Buy |
276
+31
| +13% | +$2.7K | ﹤0.01% | 558 |
|
|
2021
Q3 | $19K | Buy |
245
+15
| +7% | +$1.16K | ﹤0.01% | 590 |
|
|
2021
Q2 | $19K | Buy |
230
+6
| +3% | +$496 | ﹤0.01% | 584 |
|
|
2021
Q1 | $17K | Buy |
224
+2
| +0.9% | +$152 | ﹤0.01% | 568 |
|
|
2020
Q4 | $19K | Buy |
222
+196
| +754% | +$16.8K | ﹤0.01% | 539 |
|
|
2020
Q3 | $2K | Sell |
26
-67
| -72% | -$5.15K | ﹤0.01% | 966 |
|
|
2020
Q2 | $11K | Buy |
93
+67
| +258% | +$7.93K | ﹤0.01% | 468 |
|
|
2020
Q1 | $2K | Buy |
26
+18
| +225% | +$1.39K | ﹤0.01% | 677 |
|
|
2019
Q4 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 862 |
|
|
2019
Q3 | – | Sell |
-50
| Closed | -$4K | – | 1066 |
|
|
2019
Q2 | $4K | Sell |
50
-6
| -11% | -$480 | ﹤0.01% | 573 |
|
|
2019
Q1 | $5K | Buy |
56
+48
| +600% | +$4.29K | ﹤0.01% | 535 |
|
|
2018
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 604 |
|
|
2018
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 652 |
|
|
2018
Q2 | $1K | Buy |
8
+4
| +100% | +$500 | ﹤0.01% | 627 |
|
|
2018
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 751 |
|